October 25, 2011
Daiichi Sankyo and AstraZeneca K.K. (AZ) announced on October 24 that AZ applied on October 21 for an additional indication for the proton pump inhibitor (PPI) Nexium (esomeprazole) 10 mg and 20 mg capsules with the Ministry of Health, Labor...read more